Waist circumference and cardiovascular risk factors;Perímetro de cintura y factores de riesgo cardiovascular

Revista Espanola de Obesidad

Volumn 6, Issue 2, 2008, Pages 97-104

  Martínez Hervás, Sergio ^a   Romero, Pedro ^b   Ferri, Jordi ^a   Pedro, Teresa ^a   Real, José T ^a   Priego, Antonia ^a   Martínez Valls, José F ^a   Ascaso, Juan F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Centro de Salud de Picassent   (Spain)

Author keywords

Abdominal obesity; Cardiovascular risk factors; Metabolic syndrome; Waist circumference

Indexed keywords

APOLIPOPROTEIN B; BICARBONATE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; OUTPATIENT DEPARTMENT; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 77956654433     PISSN: 16966112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gutiérrez-Fisac JL, Banegas-Banegas JR, Artalejo FR, Regidor E. Increasing prevalence of overweight and obesity among Spanish adults, 1987-1997. Int J Obes Relat Metab Disord 2000; 24: 1677-82.
2. Aranceta J, Pérez C, Serra L, Ribas L, Quiles J, Viopque J, et al. Prevalencia de la obesidad en España: resultados del estudio SEEDO 2000. Med Clin (Barc) 2003; 120: 608-12.
3. Ascaso JF, Romero P, Real JT, Lorente RI, Martínez-Valls J, Carmena R. Abdominal adiposity (waist circumference) and its relation to insulin resistance and the metabolic syndrome in a South European Population. Eur J Intern Med 2003; 14: 101-6.
4. Lemieux S. Contribution of visceral obesity to the insulin resistance syndrome. Can J Appl Physyol 2001; 26: 273-90. (Pubitemid 33602747)
5. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagital diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
6. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996; 64: 685-93.
7. Concepción L, Martí-Bonmatí L, Aliaga R, Delgado F, Morillas C, Hernández A. Estudio de la grasa abdominal mediante resonancia magnética: comparación con parámetros antropométricos y de riesgo cardiovascular. Med Clin (Barc) 2001; 117: 366-9.
8. Després JP, Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994; 236: 7-22.
9. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Geneva (Switzerland): Department of Noncommunicable Disease Surveillance; 1999.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
11. The IDF consensus worldwide definition of the metabolic syndrome. Disponible en: htpp://www.idf.org.
12. Formiguera X. Circunferencia de la cintura y riesgo cardiovascular en población española. Clin Invest Arterioscl 2007; 19: 90-1.
13. Bray GA. Pathophysiology of obesity. Am J Clin Nutr 1992; 55: 488S-94S.
14. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-61.
15. Alain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
16. Wahlefeld AW. Triglycerides: determination after enzymatic hydrolisis. En: Bergmeyer HU (ed.). Methods of enzymatic analysis. New York: Academic Press; 1974. p. 1831-5.
17. Sociedad Española de Arteriosclerosis. Manual de las clínicas españolas de lípidos. Madrid: Jarpyo Editores; 1992.
18. Marcovina SM, Albers JJ, Dati F, Ledue TB, Ritchie RF. International Federation of Clinical Chemistry standarization Project for measurementes of apolipoproteins AI and B. Clin Chem 1991; 37: 1676-82. (Pubitemid 21892726)
19. Kadish AH, Litle RH, Sternberg JC. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1986; 14: 116-31.
20. Berson S, Yellow RS. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 1959; 38: 1996-2016.
21. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Med Clin (Barc) 2001; 117: 530-3.
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Circulation 2005; 112: 2735-52.
23. Gutiérrez-Fisac JL. Regidor E, Banegas JR, Rodríguez Artalejo F. Prevalencia de obesidad en la población adulta española: 14 años de incremento continuado. Med Clin (Barc) 2005; 124: 196-7.
24. Guallar-Castillón P, Banegas Banegas JR, García de Yébenes MJ, Gutiérrez-Fisac JL, López García E, Rodríguez-Artalejo F. Asociación de la enfermedad cardiovascular con el sobrepeso y la obesidad en España. Med Clin (Barc) 2002; 118: 616-8.
25. Martínez JA, Moreno B, Martínez-González A. Prevalence of obesity in Spain. Obes Rev 2004; 5: 171-2.
26. De Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F. Prevalence of obesity in a Canarian community. Association with type 2 diabetes mellitus: the Guía Study. Eur J Clin Nutr 2002; 56: 557-60.
27. Soriguer F, Rojo-Martínez G, Esteva de Antonio I, Ruiz de Adana MS, Catalá M, Merelo MJ, et al. Prevalence of obesity in south-east Spain and its relation with social and health factors. Eur J Epidemiol 2004; 19: 33-40. (Pubitemid 38250051)
28. Quiles J, Vioque J. Prevalencia de obesidad en la Comunidad Valenciana. Med Clin (Barc) 1998; 110: 319.
29. Ascaso JF. La cintura hipertrigliceridémica. Clin Invest Arterioscl 2005; 17: 286-96.
30. Millán J, Mantilla T, Aranceta J, Foz M, Gil B, Jover E, et al. Parámetros antropométricos asociados al riesgo cardiovascular en España. Estudio DORICA. Clin Invest Arterioscler 2007; 19: 61-9.
31. Chul Sung K, Ryuc S, Reaven GM. Relationship between obesity and several cardiovascular disease risk factors in apparently healthy Korean individuals: comparison of body mass index and waist circumference. Metabolism 2007; 56: 297-303. (Pubitemid 46210214)
32. Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K; for the WHO MONICA Project. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 Populations of the WHO MONICA Project. J Clin Epidemiol 1999; 52: 1213-24.
33. Farin HMF, Abbasi F, Reaven GN. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol 2006; 98: 1053-6. (Pubitemid 44486142)
34. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-8.
35. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
36. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
37. Okosun IS, Chandra KM, Boev A, Boltri JM, Choi ST, Parish DC, et al. Abdominal adiposity in U.S. adults: prevalence and trends, 1960-2000. Prev Med 2004; 39: 197-206.
38. Álvarez León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc) 2003; 120: 172-4.
39. De Pablos Velasco PL, Martínez Martín FJ. Significado clínico de la obesidad abdominal. Endocrinol Nutr 2007; 54: 265-71.